3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
5
Leukemia, Hairy Cell
3
Burkitt Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Non-Hodgkin
2
Hodgkin Disease
2
Carcinoma in Situ
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Vomiting
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Nausea and Vomiting
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
NSCLC
1
Myelodysplastic Syndromes
1
Mastocytosis, Systemic
1
Lymphoma, Follicular
1
Lymphoma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
pembrolizumab
91
Carboplatin
79
Specimen Handling
76
Magnetic Resonance Spectroscopy
64
Pemetrexed
60
Cisplatin
49
durvalumab
44
Paclitaxel
38
Nivolumab
34
atezolizumab
32
Radiotherapy
30
Radiosurgery
30
osimertinib
29
Blood Specimen Collection
27
Biopsy
26
Gemcitabine
24
Docetaxel
24
Immunoglobulin G
23
Standard of Care
22
Disulfides
22
Etoposide
21
Drug Therapy
21
Taxes
18
Practice Guidelines as Topic
18
Radiation
17
Educational Status
16
130-nm albumin-bound paclitaxel
15
X-Rays
14
Surveys and Questionnaires
14
Bevacizumab
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Diphenhydramine
×
1 year
×
Clear all
No trials found.